• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“环丙基片段”是一种经常出现在临床前/临床药物分子中的多功能成分。

The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules.

作者信息

Talele Tanaji T

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University , 8000 Utopia Parkway, Queens, New York 11439, United States.

出版信息

J Med Chem. 2016 Oct 13;59(19):8712-8756. doi: 10.1021/acs.jmedchem.6b00472. Epub 2016 Jun 30.

DOI:10.1021/acs.jmedchem.6b00472
PMID:27299736
Abstract

Recently, there has been an increasing use of the cyclopropyl ring in drug development to transition drug candidates from the preclinical to clinical stage. Important features of the cyclopropane ring are, the (1) coplanarity of the three carbon atoms, (2) relatively shorter (1.51 Å) C-C bonds, (3) enhanced π-character of C-C bonds, and (4) C-H bonds are shorter and stronger than those in alkanes. The present review will focus on the contributions that a cyclopropyl ring makes to the properties of drugs containing it. Consequently, the cyclopropyl ring addresses multiple roadblocks that can occur during drug discovery such as (a) enhancing potency, (b) reducing off-target effects,

摘要

最近,环丙基在药物研发中的应用越来越多,用于将候选药物从临床前阶段推进到临床阶段。环丙烷环的重要特征包括:(1)三个碳原子共平面;(2)碳-碳键相对较短(1.51 Å);(3)碳-碳键的π特性增强;(4)碳-氢键比烷烃中的碳-氢键更短、更强。本综述将聚焦于环丙基对含环丙基药物性质的贡献。因此,环丙基克服了药物发现过程中可能出现的多个障碍,例如(a)增强效力,(b)减少脱靶效应,

相似文献

1
The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules.“环丙基片段”是一种经常出现在临床前/临床药物分子中的多功能成分。
J Med Chem. 2016 Oct 13;59(19):8712-8756. doi: 10.1021/acs.jmedchem.6b00472. Epub 2016 Jun 30.
2
Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.通过设计改进候选药物:关注物理化学性质,以改善化合物处置和安全性。
Chem Res Toxicol. 2011 Sep 19;24(9):1420-56. doi: 10.1021/tx200211v. Epub 2011 Jul 26.
3
Strategies at the interface of drug discovery and development: early optimization of the solid state phase and preclinical toxicology formulation for potential drug candidates.药物发现与开发交叉领域的策略:潜在候选药物的固态相早期优化及临床前毒理学制剂研究
J Med Chem. 2010 Aug 26;53(16):5897-905. doi: 10.1021/jm1002638.
4
Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space.改进药物设计:效率指标近期应用、替换有问题元素的策略以及非传统药物领域化合物的最新进展
Chem Res Toxicol. 2016 Apr 18;29(4):564-616. doi: 10.1021/acs.chemrestox.6b00043. Epub 2016 Mar 14.
5
Cyclopropyl Scaffold: A Generalist for Marketed Drugs.环丙基骨架:畅销药物的多面手。
Mini Rev Med Chem. 2021;21(2):150-170. doi: 10.2174/1389557520666200729161150.
6
What happened to the modeling and simulation revolution?建模与仿真革命怎么了?
Clin Pharmacol Ther. 2014 Oct;96(4):416-7. doi: 10.1038/clpt.2014.123.
7
Pharmacokinetics and the drug-target residence time concept.药代动力学和药物靶点停留时间概念。
Drug Discov Today. 2013 Aug;18(15-16):697-707. doi: 10.1016/j.drudis.2013.02.010. Epub 2013 Mar 14.
8
3D molecular descriptors important for clinical success.对临床成功有重要意义的 3D 分子描述符。
J Chem Inf Model. 2013 Feb 25;53(2):327-42. doi: 10.1021/ci300445e. Epub 2013 Jan 18.
9
The role of pharmacokinetic and pharmacokinetic/pharmacodynamic modeling in drug discovery and development.药代动力学和药代动力学/药效学建模在药物发现与开发中的作用。
Future Med Chem. 2010 Jun;2(6):923-8. doi: 10.4155/fmc.10.181.
10
Impact of modeling and simulation: myth or fact?建模与仿真的影响:神话还是事实?
Clin Pharmacol Ther. 2014 Oct;96(4):413-5. doi: 10.1038/clpt.2014.122.

引用本文的文献

1
Novel guanidine derivatives as mechanistic scaffolds for anticancer agents: synthesis, characterization, DNA-binding, and computational studies.新型胍衍生物作为抗癌剂的作用机制支架:合成、表征、DNA结合及计算研究
RSC Adv. 2025 Sep 2;15(38):31548-31563. doi: 10.1039/d5ra05647k. eCollection 2025 Aug 29.
2
Photoredox-catalyzed cyclopropanation of allenes towards vinyl-cyclopropanes.光氧化还原催化的丙二烯环丙烷化反应合成乙烯基环丙烷。
Chem Sci. 2025 Aug 14. doi: 10.1039/d5sc05057j.
3
Synthesis of chiral difluoromethyl cyclopropanes through desymmetric difluoromethylation of cyclopropenes enabled by enantioselective copper catalysis.
通过对映选择性铜催化实现环丙烯的去对称二氟甲基化反应合成手性二氟甲基环丙烷。
Nat Synth. 2025 May 22. doi: 10.1038/s44160-025-00809-4.
4
Palladium-Catalyzed Monoarylation of Cyclopropylamine.钯催化环丙胺的单芳基化反应
J Org Chem. 2025 Aug 29;90(34):12153-12162. doi: 10.1021/acs.joc.5c01233. Epub 2025 Aug 20.
5
Modular Synthetic Platform for the Elaboration of Fragments in Three Dimensions for Fragment-Based Drug Discovery.用于基于片段的药物发现的三维片段构建模块化合成平台。
J Am Chem Soc. 2025 Jul 30. doi: 10.1021/jacs.5c08786.
6
Unravelling the target landscape of tranylcypromines for new drug discovery.解析反苯环丙胺的靶点格局以用于新药研发。
Acta Pharm Sin B. 2025 Jun;15(6):2985-3007. doi: 10.1016/j.apsb.2025.04.012. Epub 2025 Apr 14.
7
Elementary Steps in Olefin Metathesis: Nickelacyclobutanes via Cycloaddition to Nickel Carbenes.烯烃复分解反应的基本步骤:通过环加成到镍卡宾生成镍杂环丁烷。
J Am Chem Soc. 2025 Jul 16;147(28):24225-24229. doi: 10.1021/jacs.5c06505. Epub 2025 Jul 7.
8
Boron-chalcogen heterocycles and linear tetraboranes from a cyclic tetra(amino)tetraborane.由环状四(氨基)四硼烷合成的硼-硫族元素杂环和线性四硼烷。
Nat Commun. 2025 Jun 12;16(1):5304. doi: 10.1038/s41467-025-60549-z.
9
Water-Catalytic Deconstructive and Proton Transfer Cyclopropanation of Sulfoxonium Ylide with Olefin.水催化的叶立德与烯烃的解构及质子转移环丙烷化反应
Adv Sci (Weinh). 2025 Aug;12(31):e02430. doi: 10.1002/advs.202502430. Epub 2025 May 30.
10
An optimized CYP3A4-activatable fluorogenic sensor for functional imaging and multi-dimensional inhibitor assessment.一种用于功能成像和多维抑制剂评估的优化的CYP3A4可激活荧光传感器。
Chem Sci. 2025 May 23. doi: 10.1039/d5sc01791b.